Background: Prescriptions for gastric acid-suppressive agents, including proton-pump inhibitors (PPIs) and histamine type-2 receptor antagonists (H2RAs), are rising. However, little data exist regarding their association with dementia in the Asian population. The objective of this study was thus to investigate the impact of the use of PPIs and H2RAs on the risk of dementia in an Asian population with upper gastrointestinal disease (UGID).
Methods: We conducted a population-based retrospective cohort study with a 10-year follow-up using data from 2000 to 2015 derived from Taiwan's Longitudinal Health Insurance Database. We included 6711 patients with UGID receiving gastric acid-suppressive agents, 6711 patients with UGID not receiving agents, and 6711 patients without UGID or treatment thereof, all at least 20 years of age. Groups were matched for age, sex, and index date. The association between gastric acid-suppressive agent use and dementia was analyzed using a Cox proportional hazards regression model adjusted for potential confounders.
Results: The adjusted hazard ratio (aHR) of dementia for patients with UGID receiving gastric acid-suppressive agents compared with patients with UGID without gastric acid-suppressive agents was 1.470 (95% confidence interval [CI] 1.267-1.705, p < 0.001). Both PPIs and H2RAs increase the risk of dementia (PPIs: aHR 1.886 [95% CI 1.377-2.582], p < 0.001; H2RAs: aHR 1.357 [95% CI 1.098-1.678], p < 0.01), with PPIs exhibiting significantly greater risk (aHR 1.456 [95% CI 1.022-2.075], p < 0.05).
Conclusions: Our results demonstrate an increased risk of dementia in patients with UGID receiving gastric acid-suppressive agents, including PPIs and H2RAs, and the use of PPIs was associated with a significantly greater risk than H2RA use.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993796 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249050 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Association between acid-suppressive drugs and risk of psoriasis: retrospective study using Korean National Health Insurance Service-National Sample Cohort.
Korean J Intern Med
January 2025
Department of Dermatology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Korea.
Background/aims: Psoriasis is a common inflammatory skin disorder following non-specific triggers. Involvement of immune system is widely accepted for pathogenesis studies have demonstrated importance of gut microbiota in pathogenesis of inflammatory skin diseases. Proton pump inhibitor (PPI) and histamine-2 receptor antagonist (H2RA) are acid-suppressive drugs widely used for acid related gastrointestinal diseases, and prolonged use has been associated with altered gut microbiota.
View Article and Find Full Text PDFEfficacy of the Bridge Dry Swallowing Exercise for Refractory Gastroesophageal Reflux Disease.
Intern Med
December 2024
Department of Rehabilitation Medicine, Hamamatsu City Rehabilitation Hospital, Japan.
Background Gastroesophageal reflux disease (GERD) is a condition characterized by reflux of gastric contents, leading to damage to the esophageal mucosa and/or unpleasant symptoms, with a global prevalence of 13%. Although acid-suppressive medications are currently the most effective treatments for GERD, they may be ineffective against its symptoms. We therefore investigated the efficacy of a physical exercise program for the treatment of intractable GERD symptoms.
View Article and Find Full Text PDFDeprescribing strategies for proton pump inhibitors.
JAAPA
November 2024
Julia Young, Jordan A. Fuller, and Corey M. Guidry are assistant professors at the University of Oklahoma College of Pharmacy in Oklahoma City, Okla. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Article Synopsis
- Proton pump inhibitors (PPIs) are commonly used medications for treating gastric-acid related diseases due to their effectiveness and better tolerability compared to other treatments.
- Long-term use of PPIs can lead to various adverse reactions, highlighting the need for careful management of their use.
- The article outlines guidelines for both short- and long-term PPI use and provides strategies for clinicians to safely reduce unnecessary prescriptions.
Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
BMC Gastroenterol
May 2024
Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital, 1-12-1 Shimoteno, 670-8540, Himeji, Japan.
Background: At present, eradication regimens for non-Helicobacter pylori Helicobacter (NHPH) have not been established yet. We investigated effectiveness of the standard triple-drug combination therapy for Helicobacter pylori eradication and of a proton pump inhibitor (PPI) monotherapy in eradication of NHPH.
Methods: Subjects were the patients who were diagnosed with NHPH-infected gastritis based on microscopic findings, helical-shaped organisms obviously larger than Helicobacter pylori, in the gastric mucosal specimens using Giemsa staining at Kenwakai Hospital between November 2010 and September 2021, whose NHPH species were identified by polymerase chain reaction (PCR) analysis of urease genes in endoscopically-biopsied samples, and who consented to NHPH eradication with either the triple-drug combination therapy for one week or a PPI monotherapy for six months.
Sporadic gastrinoma with refractory benign esophageal stricture: A case report.
World J Clin Cases
March 2024
Department of Gastroenterology, First Affiliated Hospital of Anhui Medical University, Hefei 230001, Anhui Province, China.
Article Synopsis
- - Gastrinoma leads to excess gastrin production, resulting in increased gastric acid and recurring health issues like peptic ulcers and chronic diarrhea, coupled with complications such as esophageal strictures.
- - A case study illustrates a patient with gastrinoma who faced refractory benign esophageal stricture (RBES) and complete esophageal blockage, despite various treatments aimed at reducing acid secretion.
- - Early diagnosis of gastrinoma is crucial; prolonged uncontrolled acid can significantly heighten the risk of severe esophageal strictures, making treatment options like endoscopic procedures risky and complex.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!